Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
COST-BENEFIT EVALUATION OF DRUG-TREATMENT FOR ALZHEIMERS-DISEASE
Autore:
KANOWSKI S;
Indirizzi:
FREE UNIV BERLIN,DEPT GERONTOSPSYCHIAT,ESCHENALLEE 3 D-14050 BERLIN GERMANY
Titolo Testata:
Archives of gerontology and geriatrics
, , anno: 1998, supplemento:, 6
pagine: 275 - 280
SICI:
0167-4943(1998):<275:CEODFA>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
SPOUSE-CAREGIVERS; DEMENTIA; TACRINE; HOME;
Keywords:
ALZHEIMERS DISEASE; DRUG TREATMENT OF DEMENTIA; COST-BENEFIT RATIO IN DRUG TREATMENT OF DEMENTIA;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
14
Recensione:
Indirizzi per estratti:
Citazione:
S. Kanowski, "COST-BENEFIT EVALUATION OF DRUG-TREATMENT FOR ALZHEIMERS-DISEASE", Archives of gerontology and geriatrics, 1998, pp. 275-280

Abstract

On the background of an ongoing discussion on the cost-benefit relation of nootropic drugs, the whole scope and the dimensions of the problem have to be considered. This will be done with a short view on diagnostics as a prerequisit of proper treatment. Then a comprehensive treatment program has to be outlined demonstrating that drug therapy can be only one factor in alleviating the burden of patients and their families. Against that background the results of a few types of experimental, ''quasi'' experimental and theoretical studies will be reported which give some evidence that drug induced improvement is economically effective. The main outcome criteria which should be used are: Slowing of progression of dementia process, avoidance or postponing of longterm institutionalization, alleviation of the burden, and the amount of needed support by caregivers.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/04/20 alle ore 09:04:24